Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Iterum Therapeutics plc (ITRM)

3.03   0.09 (3.06%) 02-20 16:00
Open: 3 Pre. Close: 2.94
High: 3.41 Low: 2.86
Volume: 112,386 Market Cap: 45M
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The company is developing sulopenem, a novel penem anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was founded in 2015 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.414 - 3.427 3.427 - 3.44
Low: 2.83 - 2.844 2.844 - 2.857
Close: 3.007 - 3.029 3.029 - 3.051

Technical analysis

as of: 2020-02-20 4:41:09 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 4.42     One year: 5.55
Support: Support1: 2.22    Support2: 1.85
Resistance: Resistance1: 3.78    Resistance2: 4.75
Pivot: 2.58
Moving Average: MA(5): 2.78     MA(20): 2.60
MA(100): 3.28     MA(250): 5.41
MACD: MACD(12,26): -0.12     Signal(9): -0.20
Stochastic oscillator: %K(14,3): 77.60     %D(3): 77.12
RSI: RSI(14): 54.28
52-week: High: 9.30  Low: 1.68  Change(%): -46.0
Average Vol(K): 3-Month: 32999  10-Days: 6599

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ITRM has closed It is unclear right now based on current numbers. 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ITRM's normal range. The bands have been in this narrow range for 8 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Fri, 17 Jan 2020 14:14:23 +0000
Health Care Sector Update for 01/17/2020: DRRX, ITRM, LLY, JNJ, PFE, ABT, MRK, AMGN

Wed, 11 Dec 2019 01:28:55 +0000
FDA Panel Says No To CORV, ITRM For Sure Has Disappointed, ELOX, XERS On Watch

Wed, 04 Dec 2019 01:38:26 +0000
Today's Top Gainers: OTLK Well Visioned, BCEL On The Move, ITRM On Watch

Thu, 31 Oct 2019 05:30:20 +0000
Top 5 Losers In Healthcare Sector (CYCN, AMAG, ELGX…)

Mon, 25 Mar 2019 16:32:38 +0000
Mid-Day Market Update: Iterum Therapeutics Gains After Q4 Results; Proteostasis Therapeutics Shares Slide

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGM
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 14.42
Shares Float (M) 4.99
% Held by Insiders 3.58
% Held by Institutions 72.96
Shares Short (K) 277
Shares Short P. Month (K)

Stock Financials

EPS -7.302
Book Value (p.s.) -0.210
PEG Ratio
Profit Margin
Operating Margin -37241.31
Return on Assets (ttm) -76.6
Return on Equity (ttm) -228.0
Qtrly Rev. Growth
Gross Profit (p.s.) 0.060
Sales Per Share
EBITDA (p.s.) -7.118
Qtrly Earnings Growth
Operating Cash Flow (M) -82.69
Levered Free Cash Flow (M) -43.21

Stock Valuations

P/E -0.41
P/E Growth Ratio 0.03
P/BV -14.43
P/S 151.50
P/CF -0.53

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.